Trial 16M-15-2


A Phase 1b Study of REOLYSIN® combined with Standard Doses of Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Type: Treatment
Phase: Phase I
Status: Closed to Accrual with Ongoing Follow-up
Treatments: Chemotherapy: Systemic
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Kevin Kelly, M.D.
Other Trial Staff:  Ashot Minasyan, D.M., Christine Duran, Coordinator, Ibrahim Syed, Coordinator, Donna Fernando, R.N., Ibrahim Meena, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.